RECRUITING

Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies

Description

This study will evaluate if a direct-to-patient, de-centralized, remote approach will improve clinical research outreach and engagement for patients with SCLC, in the context of a bio-specimen collection study. The study will also assess self-reported preferences and needs of patients with SCLC, regarding choosing and accessing novel therapies in research or standard clinical care settings and supportive gaps in this area, through an initial and 3 month follow up survey.

Conditions

Small-cell Lung Cancer
Talk to us

Related Conditions:

Small-cell Lung Cancer

Study Overview

On this page

Study Details

Study overview

This study will evaluate if a direct-to-patient, de-centralized, remote approach will improve clinical research outreach and engagement for patients with SCLC, in the context of a bio-specimen collection study. The study will also assess self-reported preferences and needs of patients with SCLC, regarding choosing and accessing novel therapies in research or standard clinical care settings and supportive gaps in this area, through an initial and 3 month follow up survey.

A Study to Evaluate a Remote, Decentralized, Direct-to-Patient Strategy for Clinical Research Engagement of Patients With Small Cell Lung Cancer (SCLC), in the Context of a Bio-specimen Collection Study, and to Identify Patient-Reported Preferences and Needs Regarding Choosing and Accessing Novel Therapies and Supportive Gaps.

Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies

Condition
Small-cell Lung Cancer
Intervention / Treatment

-

Contacts and Locations

Nashville

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States, 37232

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Men or women greater than or equal to 18 years of age at the time of consent
  • 2. Ability to read, write and communicate in English
  • 3. Provide voluntary consent to participate in this study, documented via a signed informed Consent Form (ICF)
  • 4. Willing to provide clinical and medical information related to his/her cancer diagnoses to the study team as required
  • 5. Willing to comply with the requirements of the study
  • 6. Diagnosis of extensive stage primary SCLC or tSCLC
  • 1. Known existence of an uncontrolled intercurrent illness including, but not limited to, psychiatric illness or social situations that would impair compliance with study requirements
  • 2. Subjects who previously enrolled to this study

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Addario Lung Cancer Medical Institute,

Christine Lovly, MD PhD, PRINCIPAL_INVESTIGATOR, Vanderbilt-Ingram Cancer Center, Nashville, TN

Study Record Dates

2027-06